Despite its flaws, the N54 earned widespread acclaim, winning multiple international awards. Its combination of a pair of ...

The port delivery system (PDS) formulation of ranibizumab – a VEGF inhibitor already approved as Lucentis to treat wet AMD – was able to extend the time between treatments for six months or ...